Speedskater Erin Jackson, who won a gold medal at the 2022 Beijing Winter Olympics, talks about how eczema has affected her, ...
Investor's Business Daily on MSN
Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue
Sanofi stock jumped early Friday on better-than-expected third-quarter sales and earnings, and a strong showing from Dupixent ...
Everyday Health on MSN
Chronic Idiopathic Urticaria Treatment: Medication, Lifestyle Changes, and More
Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...
There are some 40 interleukins that play a wide variety of roles in inflammation and the body’s immune response, some of them hitting the accelerator and others tapping the brakes. When it comes to ...
Dupixent (dupilumab) has been a breakthrough treatment for people with severe eczema, asthma, and other inflammatory ...
When you start a medication like Dupixent (dupilumab), you expect relief from eczema or asthma, not the devastation of a cancer diagnosis. Yet ...
Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
Dupixent is prescribed to asthma patients as well as for treatment of chronic obstructive pulmonary disease (COPD), chronic sinusitis, nasal polyps, eosinophilic esophagitis, and moderate to severe ...
Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...
An oral GLP-1 receptor agonist, Rybelsus will be available in 7-mg and 14-mg doses. "As the only FDA-approved GLP-1 therapy in a pill, now recognized for its proven cardiovascular benefits, a new ...
Digital health platform Hello Heart is launching a new suite of medication management tools for people at risk of heart disease, including an AI assistant for heart health. Through a connected blood ...
Nektar Therapeutics' leading candidate is performing well so far in phase 2 studies. This medicine could disrupt the large and competitive eczema treatment market. Nektar could match Wall Street's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results